The Role of Carotid Flow Time-Based Fluid Administration in Caesarean Section
1 other identifier
observational
72
1 country
2
Brief Summary
It has been reported that corrected carotid flow time (FTc) may indicate the responsiveness of spontaneously breathing patients to fluid therapy. The primary objective of the study is to determine the effect of fluid preload applied to patients with preanesthetic FTc values below the cut-off value on the incidence of hypotension in cesarean section (C/S) surgery. Pregnant women who underwent cesarean section under spinal anesthesia were included in this prospective study. In the preoperative care unit, patients were assigned to two groups according to their baseline FTc values. Patients with baseline FTc \< 327 ms were assigned to the first group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc \> 327 ms. On the other hand, patients with baseline FTc \> 327 ms were assigned to the second group, and preload fluid was not administered to these patients. Intraoperative hemodynamic data were recorded for each patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2022
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2023
CompletedFirst Submitted
Initial submission to the registry
September 15, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedSeptember 28, 2023
September 1, 2023
6 months
September 15, 2023
September 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of intra-operative hypotension
Hypotension definitions included systolic arterial pressure (SAP) below 80 mmHg, or mean arterial pressure (MAP) below 65 mmHg, or a decrease in SAP of more than 30% below baseline, or a decrease in MAP of more than 20% below baseline, or any combination of all these definitions.
During surgery
Study Arms (2)
Preload
Patients with baseline FTc \< 327 ms were assigned to the preload group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc \> 327 ms.
Non-preload
Patients with baseline FTc \> 327 ms were assigned to the non-preload group, and preload fluid was not administered to these patients
Interventions
Preoperative FTcs of pregnant women who underwent C/S operation were measured, and those below the cut-off value (327 ms) determined in previous studies were preloaded with Ringer Lactate until FTc was \> 327 ms.
Eligibility Criteria
ASA II pregnant women between the ages of 20 and 40 who were undergoing elective cesarean section, and had uncomplicated singleton term pregnancies, and agreed to participate in the study were included.
You may qualify if:
- years of age pregnant women
- American Society of Anesthesiologists (ASA) physical status-II patients
- Uncomplicated, singleton, term pregnancy
- Elective C/S surgery
You may not qualify if:
- Placental disorders
- Gestational hypertensive disorders
- Morbid obesity (BMI\>39 kg/m2)
- Carotid stenosis more than 50%
- Baseline SAP more than 160 mmHg
- Arrhythmia
- History of cardiovascular or cerebrovascular disease, and chronic kidney disease (estimated glomerular filtration rate \<60 mL/min/1.73 m2)
- Emergency surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Cukurova University
Adana, Saricam, 01330, Turkey (Türkiye)
Çukurova University; Faculty of Medicine
Adana, Sarıçam, 01330, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Demet Laflı Tunay, Dr.
Çukurova University, Balcalı Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 15, 2023
First Posted
September 21, 2023
Study Start
November 15, 2022
Primary Completion
May 20, 2023
Study Completion
July 5, 2023
Last Updated
September 28, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
All data were anonymized by the local researcher. Therefore, data collection was pseudonymous and the patient's name did not appear on any case report form or other study document. All collected data were kept confidential. This study was conducted in accordance with the revision of the Declaration of Helsinki (2008). International Conference on Harmonisation-Good Clinical Practice (ICH-GCP) was strictly adhered to.